TrovaGene

Shares of TrovaGene Inc (NASDAQ: TROV), a molecular diagnostic company, gained more than 2 percent on Friday after the company announced that it was favorably mentioned in a medical journal. TrovaGene said a patient case report feature use of its Precision Cancer Monitoring technology was...

Shares of TrovaGene Inc (NASDAQ: TROV) were trading lower by more than 40 percent early Tuesday morning after the company announced the termination of its CEO and CFO for cause. TrovaGene announced after Monday's market close that its Board of Directors terminated the employment of its CEO...